Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL135P (RNA, 7SL, cytoplasmic 135, pseudogene) is a *pseudogene*—a nonfunctional segment of DNA derived from the 7SL RNA gene, itself a crucial component of the signal recognition particle (SRP) that mediates cotranslational protein targeting to the endoplasmic reticulum[3][6]. Pseudogenes such as RN7SL135P are characterized by sequence similarity to functional genes but lack the regulatory elements or essential coding capacity for producing functional molecules or participating in physiological processes[4][6]. The majority of 7SL-related sequences in the human genome are pseudogenes with truncated or mutated sequences; they are not transcribed into functional RNA and do not serve as molecular targets for drugs, nor are they therapeutic targets or biomarkers[6]. RN7SL135P is a *pseudogene*, not a receptor, enzyme, or traditional drug target. It shares sequence similarity with functional 7SL RNA but is not functional itself[6]. It is not associated with disease roles, biomarkers, or therapeutic functions[4]. There are no known drugs, mechanisms, or safety considerations directly related to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 135, pseudogene (RN7SL135P).